More than 20% of cancer patients skipped recommended treatments because they feared the high out-of-pockets for their care, a new survey shows, while almost half said their costs were higher than expected.
The Cancer Support Community (CSC) survey of more than 1,000 cancer patients comes as the Senate prepares to vote next week on sweeping legislation that would speed the approval process for prescription drugs but doesn’t address the issue of high drug prices. It also comes amid a flurry of reports on high health care costs — and especially the financial toxicity of cancer. A report in the medical journal JAMA Oncology last week showed patients with only Medicare coverage — and no employer, government or supplemental coverage — spend nearly a quarter of their families’ incomes on cancer treatment.
Read Full Article Here >>